BioRestorative Therapies (BRTX) has issued an announcement.
The information presented in this report, while current, won’t be considered “filed” under Section 18 of the Securities Exchange Act of 1934 and will not be liable to the associated section’s legal implications. This ensures that readers understand the document’s legal standing regarding financial disclosure and market regulations without getting into the complexities of financial jargon or legal technicalities.
See more insights into BRTX stock on TipRanks’ Stock Analysis page.
